Wendy Johnson

Member

About-us_Leadership_Wendy-Johnson
  • Year of birth 1952
  • Nationality US-American
  • Place of residence San Diego, CA, USA
  • Initial appointment 2015
  • End of current period 2022

Professional Development

Currently Consultant

2017 - 2021 Chief Business Officer, Reneo Pharmaceuticals, San Diego, CA, USA; Managing Director, Gemini Advisors, San Diego, CA, USA

2007 - 2014 Founder, President and CEO, Aires Pharmaceuticals, Inc., San Diego, CA, USA

2005 - 2014 Venture Partner, ProQuest Investments, San Diego, CA, USA

2001 - 2005 Senior Vice President Corporate Development, Salmedix, Inc., San Diego, CA, USA

2000 - 2001 Independent Consultant, San Diego, CA, USA

1998 - 2000 Vice President Business Development, Women First HealthCare, San Diego, CA, USA

1994 - 1998 Vice President Corporate Development & Operations, Selective Genetics, San Diego, CA, USA

1990 - 1994 Vice President Business Development & Regulatory Affairs, Cytel Corp., San Diego, CA, USA

1988 - 1990 Manager Business Development, Synbiotics Corp., San Diego, CA, USA

1986 - 1988 International Business Development & Regulatory Affairs Manager, Murex Corp., Cambridge, Great Britain

1976 - 1986 Assistant Director, US Food & Drug Administration, Center for Devices & Radiological Health, Rockville, MD, USA

Education

1984 - 1986 M.B.A., Loyola Marymount University, Los Angeles, CA, USA

1974 - 1976 M.S. Clinical Microbiology, Hahnemann University Hospital, Philadelphia, PA, USA

1970 - 1974 B.S. Microbiology, University of Maryland, College Park, MD, USA

Memberships in Statutory Supervisory Boards and/or in Comparable Domestic or Foreign Supervisory Bodies of Commercial Enterprises Section

Exagen, Inc., Vista, CA, USA Member of the Board of Directors

*not publicly listed company; group mandate
As of February 2022